ArticleBiometrics2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison.
Yong Zang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleBiometrics2024
Yong Zang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.